Resources

Filter by:
Or browse by popular tag:
Treatment Options

New Medicare item for PRRT (Lu-DOTA) added from 1 November 2025

Educational Videos, Forum Videos

New Treatments including Cabozantinib presented by Dr Chris Lomma

NET Patient Forum Perth 2026 - New Treatments including Cabozantinib presented by Dr Chris Lomma
Support Groups

NSW & ACT Support Groups

Educational Videos

Nutrition and NETs Webinar – the latest research

Booklets & Guides

Nutrition and Neuroendocrine Tumours

Clinical Trials

ONJCRI Immunotherapy Trial: Nivolumab & Ipilimumab for Rare and Advanced Cancers

This protocol provides an important opportunity to establish whether the combination of nivolumab & ipilimumab has efficacy in these cancers.
Support Groups

Online Support Groups

Educational Videos

Optimal Care Pathway for Neuroendocrine Tumours (NETs)

Fact Sheets

Palliative Care & End of Life Care Resource List

Fact Sheets

Para & Phaeo Factsheet

Wellness

Parenting through Cancer

Clinical Trials

PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours (PARLuNET)

PARLuNET is a phase 1 dose-escalation study designed to evaluate the safety and tolerability of talazoparib (PARP Inhibitor) in...
Other Resources

Patient Card – Bathroom

Other Resources

Patient Card – Carcinoid Crisis Medical Alert

Educational Videos, Explainer Videos

Peptide receptor radionuclide therapy (PRRT)

Forum Videos

Perth NET Patient Forum 2023

Our NET Nurses are here to help support you from diagnosis to treatment, and living well with NETs.

Free and confidential, our NET nurses are available Monday – Friday, 9am – 5pm (AEDT).